2021
DOI: 10.1111/ajt.16779
|View full text |Cite
|
Sign up to set email alerts
|

Bariatric surgery prior to transplantation and risk of early hospital re-admission, graft failure, or death following kidney transplantation

Abstract: Although obesity is a known risk factor for morbidity in the general population, there has been significant controversy over the optimal weight for patients with end-stage kidney disease (ESKD). [1][2][3][4][5][6] Weight loss prior to kidney transplantation could potentially reduce the risk of postoperative complications and delayed graft function, and improve survival. 7-9 However, for many dialysis patients, weight loss is challenging to achieve. [7][8][9] With advances in bariatric surgery techniques, there… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 30 publications
0
14
0
Order By: Relevance
“…Finally, the same discourse regarding discrimination could be raised with regards to high BMI recipients who are denied access to the waiting list because of their body weight only. From the present meta-analysis, the four studies investigating the effect of recipient BMI on the post-transplantation one-year recipient and graft survival [ 28 , 29 , 30 , 31 ] found no significant difference in obese and non-obese recipients ( p = 0.28); therefore, even if it is true that bridge interventions, such as bariatric surgery [ 45 ], are increasingly being adopted to overcome this barrier, we think that obese patients should have the same chance as their non-obese counterparts, at least for LD renal transplantation. We also believe that obesity, as a metabolic and systemic disease, leads to higher AR and DGF rates, as per our findings; therefore, an additional effort trying to maximize all the adding risk factors to graft and patient loss is advisable, with a tailored immunosuppression [ 7 ].…”
Section: Discussionmentioning
confidence: 86%
“…Finally, the same discourse regarding discrimination could be raised with regards to high BMI recipients who are denied access to the waiting list because of their body weight only. From the present meta-analysis, the four studies investigating the effect of recipient BMI on the post-transplantation one-year recipient and graft survival [ 28 , 29 , 30 , 31 ] found no significant difference in obese and non-obese recipients ( p = 0.28); therefore, even if it is true that bridge interventions, such as bariatric surgery [ 45 ], are increasingly being adopted to overcome this barrier, we think that obese patients should have the same chance as their non-obese counterparts, at least for LD renal transplantation. We also believe that obesity, as a metabolic and systemic disease, leads to higher AR and DGF rates, as per our findings; therefore, an additional effort trying to maximize all the adding risk factors to graft and patient loss is advisable, with a tailored immunosuppression [ 7 ].…”
Section: Discussionmentioning
confidence: 86%
“…In addition, there were one prospective and four retrospective comparative studies in kidney transplant candidates from the USA [ 56 , 67–70 ]. Two studies covered a multidisciplinary weight-management program [ 63 65 ], two covered laparoscopic sleeve gastrectomy [ 56 , 67 ], one covered Roux-en-Y gastric bypass [ 68 ] and two reported on different bariatric procedures [ 66 , 69 , 70 ]. All studies had a high risk of confounding bias and, with the exception of one study [ 70 ], the design was such that the treatment effect on major clinical endpoints such as patient and graft survival could not be assessed.…”
Section: Chapter 4 What Are the Benefits And Harms Of Interventions Aimed At Weight Loss In Kidney Transplant Candidates With Eskd?mentioning
confidence: 99%
“…Two studies covered a multidisciplinary weight-management program [ 63 65 ], two covered laparoscopic sleeve gastrectomy [ 56 , 67 ], one covered Roux-en-Y gastric bypass [ 68 ] and two reported on different bariatric procedures [ 66 , 69 , 70 ]. All studies had a high risk of confounding bias and, with the exception of one study [ 70 ], the design was such that the treatment effect on major clinical endpoints such as patient and graft survival could not be assessed. One large study, which was based on Medicare registry data and was focussed on patients with ESKD, did not provide data on the time on the waiting list and on post-transplantation follow-up, but did report transplantation rates [ 66 ].…”
Section: Chapter 4 What Are the Benefits And Harms Of Interventions Aimed At Weight Loss In Kidney Transplant Candidates With Eskd?mentioning
confidence: 99%
See 2 more Smart Citations